Resveratrol attenuates hydrogen peroxide‑induced apoptosis, reactive oxygen species generation, and PSGL‑1 and VWF activation in human umbilical vein endothelial cells, potentially via MAPK signalling pathways

Lou,Zhenkai; Li,Xingguo; Zhao,Xueling; Du,Kaili; Li,Xing; Wang,Bing

doi:10.3892/mmr.2017.8124

Resveratrol attenuates hydrogen peroxide‑induced apoptosis, reactive oxygen species generation, and PSGL‑1 and VWF activation in human umbilical vein endothelial cells, potentially via MAPK signalling pathways

Authors:
- Zhenkai Lou
- Xingguo Li
- Xueling Zhao
- Kaili Du
- Xing Li
- Bing Wang
View Affiliations

Affiliations: Department of Orthopaedics, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China, Department of Ultrasound, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China
Published online on: November 21, 2017 https://doi.org/10.3892/mmr.2017.8124
Pages: 2479-2487

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Reactive oxygen species (ROS) are implicated in the pathogenesis of thrombosis. Studies have reported that resveratrol exhibits antioxidative activities, however, the effect and underlying mechanisms of resveratrol on venous thrombosis remain largely unknown. To investigate the effect of resveratrol on venous thrombosis and the underlying mechanisms, the present study investigated the effects of resveratrol on cell viability, apoptosis, ROS generation and the expression of thrombosis‑associated markers in human umbilical vein endothelial cells (HUVECs). HUVECs were pretreated with resveratrol for 2 h and incubated with hydrogen peroxide (H2O2) for 24 h prior to the evaluation of cell viability, ROS generation, apoptosis and thrombosis‑associated marker expression by performing MTT assays, 2',7'‑dichlorofluorescin diacetate reagent, flow cytometry, and reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analysis, respectively. Subsequently, to validate whether resveratrol functions via mitogen‑activated protein kinase (MAPK) pathways, the expression of thrombosis‑associated markers was detected by western blot analysis and RT‑qPCR following treatment of cells with resveratrol and the MAPK pathway activators anisomycin and curcumin. The results demonstrated that cell viability was markedly reduced by H2O2, and resveratrol treatment reversed the reductions in cell viability in a dose‑dependent manner. In addition, the levels of cell apoptosis and ROS generation were significantly increased by H2O2 alone, and resveratrol also reduced these effects in a dose‑dependent manner. Furthermore, the mRNA and protein expression of caspase‑3, P‑selectin glycoprotein ligand‑1 and von Willebrand factor was upregulated by H2O2 treatment in HUVECs. However, resveratrol decreased the protein expression these proteins in a dose‑dependent manner. Resveratrol also significantly inhibited the induction of phosphorylated (p)‑p38, P‑c‑Jun N‑terminal kinase and P‑extracellular signal‑regulated kinase by H2O2, and these effects were attenuated by the MAPK pathway activators anisomycin and curcumin. In conclusion, these results indicate that resveratrol protected HUVECs against oxidative stress and apoptosis. Furthermore, to the best of our knowledge, the present study is the first to demonstrate that resveratrol attenuates the expression of thrombosis‑associated markers induced by H2O2, which may occur through the suppression of the MAPK signalling pathways, indicating a potential novel therapeutic approach to prevent venous thrombosis.

View Figures

View References

1	Ashrani AA and Heit JA: Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis. 28:465–476. 2009. View Article : Google Scholar : PubMed/NCBI
2	Dixon J, Ahn E, Zhou L, Lim R, Simpson D and Merriman EG: Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at waitemata district health board: A retrospective audit. Intern Med J. 45:416–422. 2015. View Article : Google Scholar : PubMed/NCBI
3	Cha SI, Lee SY, Kim CH, Park JY, Jung TH, Yi JH, Lee J, Huh S, Lee HJ and Kim SY: Venous thromboembolism in Korean patients undergoing major orthopedic surgery: A prospective observational study using computed tomographic (CT) pulmonary angiography and indirect CT venography. J Korean Med Sci. 25:28–34. 2010. View Article : Google Scholar : PubMed/NCBI
4	Ho KM, Burrell M, Rao S and Baker R: Incidence and risk factors for fatal pulmonary embolism after major trauma: A nested cohort study. Br J Anaesth. 105:596–602. 2010. View Article : Google Scholar : PubMed/NCBI
5	López JA and Chen J: Pathophysiology of venous thrombosis. Thromb Res. 123 Suppl 4:S30–S34. 2009. View Article : Google Scholar
6	Kim YW and Byzova TV: Oxidative stress in angiogenesis and vascular disease. Blood. 123:625–631. 2014. View Article : Google Scholar : PubMed/NCBI
7	Ekim M, Sekeroglu MR, Balahoroglu R, Ozkol H and Ekim H: Roles of the oxidative stress and ADMA in the development of deep venous thrombosis. Biochem Res Int. 2014:7031282014. View Article : Google Scholar : PubMed/NCBI
8	Fan LM, Douglas G, Bendall JK, McNeill E, Crabtree MJ, Hale AB, Mai A, Li JM, McAteer MA, Schneider JE, et al: Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection. Circulation. 129:2661–2672. 2014. View Article : Google Scholar : PubMed/NCBI
9	Zeng M, Wei X, Wu Z, Li W, Li B, Fei Y, He Y, Chen J, Wang P and Liu X: Reactive oxygen species contribute to simulated ischemia/reperfusion-induced autophagic cell death in human umbilical vein endothelial cells. Med Sci Monit. 20:1017–1023. 2014. View Article : Google Scholar : PubMed/NCBI
10	Yang Y, Duan W, Liang Z, Yi W, Yan J, Wang N, Li Y, Chen W, Yu S, Jin Z and Yi D: Curcumin attenuates endothelial cell oxidative stress injury through Notch signaling inhibition. Cell Signal. 25:615–629. 2013. View Article : Google Scholar : PubMed/NCBI
11	Kostyuk VA, Potapovich AI, Suhan TO, de Luca C and Korkina LG: Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation. Eur J Pharmacol. 658:248–256. 2011. View Article : Google Scholar : PubMed/NCBI
12	Csiszár A, Csiszar A, Pinto JT, Gautam T, Kleusch C, Hoffmann B, Tucsek Z, Toth P, Sonntag WE and Ungvari Z: Resveratrol encapsulated in novel fusogenic liposomes activates Nrf2 and attenuates oxidative stress in cerebromicrovascular endothelial cells from aged rats. J Gerontol A Biol Sci Med Sci. 70:303–313. 2015. View Article : Google Scholar : PubMed/NCBI
13	Brisdelli F, D'Andrea G and Bozzi A: Resveratrol: A natural polyphenol with multiple chemopreventive properties. Curr Drug Metab. 10:530–546. 2009. View Article : Google Scholar : PubMed/NCBI
14	Guo H, Chen Y, Liao L and Wu W: Resveratrol protects HUVECs from oxidized-LDL induced oxidative damage by autophagy upregulation via the AMPK/SIRT1 pathway. Cardiovasc Drugs Ther. 27:189–198. 2013. View Article : Google Scholar : PubMed/NCBI
15	Hu YX, Cui H, Fan L, Pan XJ, Wu JH, Shi SZ, Cui SY, Wei ZM and Liu L: Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation. Can J Physiol Pharmacol. 91:1044–1054. 2013. View Article : Google Scholar : PubMed/NCBI
16	Lan F, Weikel KA, Cacicedo JM and Ido Y: Resveratrol-induced AMP-Activated protein kinase activation is cell-type dependent: Lessons from basic research for clinical application. Nutrients. 9:E7512017. View Article : Google Scholar : PubMed/NCBI
17	Abdel-Aleem GA, Khaleel EF, Mostafa DG and Elberier LK: Neuroprotective effect of resveratrol against brain ischemia reperfusion injury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/gsk3b survival pathway. Arh Physiol Biochem. 122:200–213. 2016. View Article : Google Scholar
18	Adam F, Kauskot A, Rosa JP and Bryckaert M: Mitogen-activated protein kinases in hemostasis and thrombosis. J Thromb Haemost. 6:2007–2016. 2008. View Article : Google Scholar : PubMed/NCBI
19	Lazzari MA, Sanchez-Luceros A, Woods AI, Alberto MF and Meschengieser SS: Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis. Hematology. 17 Suppl 1:S150–S152. 2012.PubMed/NCBI
20	Miszti-Blasius K, Debreceni IB, Felszeghy S, Dezso B and Kappelmayer J: Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge. Thromb Res. 127:228–234. 2011. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Bertina RM: The role of procoagulants and anticoagulants in the development of venous thromboembolism. Thromb Res. 123 Suppl 4:S41–S45. 2009. View Article : Google Scholar : PubMed/NCBI
23	Violi F and Pignatelli P: Platelet oxidative stress and thrombosis. Thromb Res. 129:378–381. 2012. View Article : Google Scholar : PubMed/NCBI
24	Wakefield TW, Myers DD and Henke PK: Role of selectins and fibrinolysis in VTE. Thromb Res. 123 Suppl 4:S35–S40. 2009. View Article : Google Scholar : PubMed/NCBI
25	Pan W, Yu H, Huang S and Zhu P: Resveratrol protects against TNF-α-induced injury in human umbilical endothelial cells through promoting sirtuin-1-induced repression of NF-KB and p38 MAPK. PLoS One. 11:e01470342016. View Article : Google Scholar : PubMed/NCBI
26	Zhou X, Chen M, Zeng X, Yang J, Deng H, Yi L and Mi MT: Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells. Cell Death Dis. 5:e15762014. View Article : Google Scholar : PubMed/NCBI
27	Zhang J, Tong N, Chen Y, Li P, Yang S and Zhao X: Resveratrol protects against vinorelbine-induced vascular endothelial cell injury. Toxicol Mech Methods. 23:665–671. 2013. View Article : Google Scholar : PubMed/NCBI
28	Matsui T and Hamako J: von Willebrand factor and von Willebrand disease. Rinsho Ketsueki. 57:2113–2123. 2016.PubMed/NCBI
29	Castaman G and Linari S: Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A. Ther Clin Risk Manag. 12:1029–1037. 2016. View Article : Google Scholar : PubMed/NCBI
30	Cerletti C, Tamburrelli C, Izzi B, Gianfagna F and de Gaetano G: Platelet-leukocyte interactions in thrombosis. Thromb Res. 129:263–266. 2012. View Article : Google Scholar : PubMed/NCBI
31	Hubert L, Darbousset R, Panicot-Dubois L, Robert S, Sabatier F, Fallague K, Dignat-George F and Dubois C: Neutrophils recruit and activate human endothelial colony-forming cells at the site of vessel injury via P-selectin glycoprotein ligand-1 and L-selectin. J Thromb Haemost. 12:1170–1181. 2014. View Article : Google Scholar : PubMed/NCBI
32	Lazzari MA, Sanchez-Luceros A, Woods AI, Alberto MF and Meschengieser SS: Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis. Hematology. 17 Suppl 1:S150–S152. 2012.PubMed/NCBI
33	Wang J, Li H, He J, Li B, Bao Q, Zhang X, Lv Z, Zhang Y, Han J, Ai D and Zhu Y: 20-Hydroxyeicosatetraenoic acid involved in endothelial activation and thrombosis. Am J Physiol Heart Circ Physiol. 308:H1359–H1367. 2015. View Article : Google Scholar : PubMed/NCBI
34	Zuchtriegel G, Uhl B, Puhr-Westerheide D, Pörnbacher M, Lauber K, Krombach F and Reichel CA: Platelets guide leukocytes to their sites of extravasation. PLoS Biol. 14:e10024592016. View Article : Google Scholar : PubMed/NCBI
35	Gao H, Liu L, Zhao Y, Hara H, Chen P, Xu J, Tang J, Wei L, Li Z, Cooper DK, et al: Human IL-6, IL-7, IL-1β, and TNF-α differently regulate the expression of pro-inflammatary related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells. Xenotransplantation. 24:e122912017. View Article : Google Scholar